share_log

海吉亞醫療:自願性公告 - 二零二四年中期業績簡報

HYGEIA HEALTH: VOLUNTARY ANNOUNCEMENT - 2024 INTERIM RESULTS PRESENTATION

HKEX ·  Aug 29 22:46
Summary by Futu AI
海吉亞醫疗控股有限公司(「海吉亞醫疗」)將於2024年8月30日舉行中期業績簡報電話會議,詳細介紹公司2024年上半年的財務業績及業務運營情況。會議將透過網絡平台進行,並提供多地區撥入號碼供投資者參與。公司強調,簡報中的前瞻性陳述存在風險和不確定性,故股東及潛在投資者不應過分依賴該等資料。海吉亞醫疗在報告中展示了其收入和毛利的顯著增長,以及手術量和專業技術人員的增加,顯示公司業務的穩健發展。此外,公司亦提到了其在肿瘤及慢病診療需求方面的專業能力和長期主義的經營策略。公司治理方面,海吉亞醫疗注重投資者關係管理,並未有減持股票的記錄,反映出創始人對公司的信心。公司亦積極回購並注銷股票,並在互聯網醫院領域取得進展,與多家保險公司建立合作。海吉亞醫疗的業務展望強調了其對ESG建設的重視和長期主義的經營理念。
海吉亞醫疗控股有限公司(「海吉亞醫疗」)將於2024年8月30日舉行中期業績簡報電話會議,詳細介紹公司2024年上半年的財務業績及業務運營情況。會議將透過網絡平台進行,並提供多地區撥入號碼供投資者參與。公司強調,簡報中的前瞻性陳述存在風險和不確定性,故股東及潛在投資者不應過分依賴該等資料。海吉亞醫疗在報告中展示了其收入和毛利的顯著增長,以及手術量和專業技術人員的增加,顯示公司業務的穩健發展。此外,公司亦提到了其在肿瘤及慢病診療需求方面的專業能力和長期主義的經營策略。公司治理方面,海吉亞醫疗注重投資者關係管理,並未有減持股票的記錄,反映出創始人對公司的信心。公司亦積極回購並注銷股票,並在互聯網醫院領域取得進展,與多家保險公司建立合作。海吉亞醫疗的業務展望強調了其對ESG建設的重視和長期主義的經營理念。
Haijia Medical Holdings Limited ("Haijia Medical") will hold a mid-term performance briefing conference call on August 30, 2024, detailing the financial performance and business operations in the first half of 2024. The meeting will be conducted through a web platform and will provide dial-in numbers for investors from multiple regions. The company emphasizes that forward-looking statements in the presentation carry risks and uncertainties, therefore shareholders and potential investors should not overly rely on such information. Haijia Medical presented significant growth in its revenue and gross profit in the report, along with an increase in surgical volume and professional technical personnel, demonstrating the steady development of the company's business. Additionally, the company mentioned its professional competence in tumor and chronic...Show More
Haijia Medical Holdings Limited ("Haijia Medical") will hold a mid-term performance briefing conference call on August 30, 2024, detailing the financial performance and business operations in the first half of 2024. The meeting will be conducted through a web platform and will provide dial-in numbers for investors from multiple regions. The company emphasizes that forward-looking statements in the presentation carry risks and uncertainties, therefore shareholders and potential investors should not overly rely on such information. Haijia Medical presented significant growth in its revenue and gross profit in the report, along with an increase in surgical volume and professional technical personnel, demonstrating the steady development of the company's business. Additionally, the company mentioned its professional competence in tumor and chronic disease treatment demands, as well as its long-term oriented operational strategy. In terms of corporate governance, Haijia Medical emphasizes investor relations management, with no record of shareholding reductions, reflecting the founder's confidence in the company. The company is also actively repurchasing and canceling stocks, making progress in the Internet hospital field, and establishing partnerships with multiple insurance companies. The business outlook of Haijia Medical emphasizes its focus on ESG construction and long-term oriented operational philosophy.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.